Public research preview

Michael C. Burgess, Representative disclosure: AbbVie Inc. Common Stock (ABBV)

Disclosed a buy transaction in AbbVie Inc. Common Stock (ABBV). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probably too late
0/100
Signal Quality
63/100
Data quality
93%
High quality

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
18 Jul 2023, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
12 days

Timeline

Transaction date

6 Jul 2023

Public disclosure

18 Jul 2023

Now

Tracked today

Filing delay: 12 days

Price movement

Complete coverage

Provider
Yahoo Finance daily close
Fetched
10 Jun 2026

Stock path

ABBV from pre-transaction context through latest close.

Bought

6 Jul 2023 · 123.257 USD · Not public yet

System decision

Would have boughtThe strategy would have bought this signal, but the entry window has closed. Simulated entry on 18 Jul 2023 at 124.015 USD. Since entry: +79.9%. Planned exit on 13 Sept 2023 after 40 trading days.

Window closed120.8179.7238.7USDDate6 Jul18 Jul8 JunOfficial disclosure18 JulPlanned exit124System buyBoughtDisclosureLatest
  • Not public yet
  • Buy window
  • Window closed
  • System buy
  • Planned exit
Observed transaction close
123.257
Observed disclosure close
124.015
Observed latest close
223.07
Pre-disclosure move
+0.6%
Post-disclosure move
+79.9%
Market-adjusted move
+79.9%
1w since disclosure
+3.7%
1m since disclosure
+9.8%
3m since disclosure
+8.9%
Pre-disclosure peak run-up
+0.6%
Retrace from peak
0.0%

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $15,001 - $50,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 18 Jul 2023, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value15001
sourcehouse_stock_act
tickerABBV
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20023340.pdf
personNameMichael C. Burgess
amountRange$15,001 - $50,000
companyNameAbbVie Inc. (ABBV)
publishedAt2023-07-18T00:00:00.000Z
rawDocumentIdraw-us-house-20023340-0
disclosureDate2023-07-18
transactionDate2023-07-06
transactionTypeP